Oramed Pharmaceuticals Inc. Financial Ratios — ORMP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-68.56	-89.15	-71.07	-39.39	-31.7	-42.98	-46.14	-50.55	-56.85	-44.04	-29.92	-27.33	3.5	-12.29	37.02
Return on Assets (%)	-54.05	-69.52	-60.65	-37.4	-30.04	-31.7	-25.7	-29.56	-34.99	-29.03	-25.76	-25.25	2.89	-10.14	33.17
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.36	- -	37.01
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-8.6	- -	-7.27
Gross Margin (%)	- -	- -	- -	- -	- -	23.56	92.39	103.51	96.67	100	100	100	100	- -	0.65
EBITDA Margin (%)	- -	- -	- -	- -	- -	-1,561	-438.36	-552.1	-540.99	-433.58	-893.3	-1,499.82	-1,162.16	- -	-748.35
Operating Margin (%)	- -	- -	- -	- -	- -	-1,561.62	-438.56	-552.35	-541.29	-433.84	-896.15	-1,501.96	-1,176.79	- -	-754.4
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-222.99	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-1,502.18	-410.42	-519.68	-519.98	-424.76	-850.5	-1,393.41	379.7	- -	3,766.2
Profit Margin (%)	- -	- -	- -	- -	- -	-1,710.45	-426.71	-519.68	-531.08	-424.76	-822.72	-1,352.61	412.31	- -	3,202.5
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-1,710.45	-426.71	-519.68	-531.08	-424.76	-822.72	-1,352.61	412.31	- -	3,202.5
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.01
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-68.56	-89.15	-71.07	-39.39	-31.7	-42.98	-46.14	-50.55	-56.85	-44.04	-29.92	-27.33	3.5	-12.29	37.02

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	52	- -	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	51	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	1
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.02	-0.02	-3.31	-0.03	-0.06
Net Debt/EBITDA	0.63	1.54	0.53	0.3	0.44	0.39	0.37	0.37	0.23	1.64	3.2	1	-2.69	4.32	3.07
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.02	-0.02	-3.27	-0.03	-0.05
Net Debt/EBIT	0.62	1.54	0.53	0.3	0.44	0.39	0.37	0.37	0.23	1.64	3.19	1	-2.66	4.26	3.05
EBITDA to Interest Expense	-128.17	-14.41	-13.72	-536.36	- -	- -	- -	- -	- -	- -	- -	- -	-7.65	-14.76	- -
EBITDA-CapEx/Interest Expense	-128.28	-14.42	-13.73	-537.64	- -	- -	- -	- -	- -	- -	- -	- -	-7.77	-14.78	- -
EBIT to Interest Expense	-129.67	-14.48	-13.73	-536.91	- -	- -	- -	- -	- -	- -	- -	- -	-7.74	-14.98	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	- -
Common Equity/Total Assets	86.08	71.35	93.89	95.37	94.21	61.15	49.7	65.64	55.95	73.67	90.45	93.92	74.28	94.2	86.52
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.35	0.43	0.21	0.11	0.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.34	0.43	0.16	0.11	0.27
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.07	0.31	0.4	0.16	0.1	0.23
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.23	0.46	0.59	31.69	0.26	0.41
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.23	0.46	0.59	24.06	0.26	0.41
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	0.42	0.55	23.41	0.24	0.36
Net Debt to Equity	-40.64	-117.28	-27.94	-8.47	-12.94	-14.92	-20.63	-16.06	-17.17	-58.69	-66.3	-26.77	25.76	-37.44	-23
Net Debt/Capital (%)	-68.46	678.8	-38.78	-9.26	-14.86	-17.53	-25.99	-19.13	-20.72	-141.28	-194.06	-36.26	20.42	-59.61	-29.72
EBITDA	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15
EBITDA-CapEx	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-25	-41	-16	-13	-17
Operating Income (Loss)	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.3	7.89	17.02	21.88	11.57	8.57	3.9	6.69	6.08	8.8	14.09	27.1	3.05	24.97	6.6
Current Ratio	9.71	8.19	17.36	22.38	11.67	8.62	3.93	6.82	6.28	8.93	14.27	27.34	3.06	25.19	6.98
Quick Ratio	5.53	8.02	17.14	22.3	11.57	8.57	3.9	6.69	6.08	8.8	14.09	27.1	3.05	24.97	6.84
CFO/Avg Current Liab	-3.79	-4.24	-5.95	-5.53	-4.02	1.82	-1.33	-3.02	-2.62	-2.53	-3.78	-4.49	-0.35	-0.29	-0.74
Common Equity/Total Assets	86.08	71.35	93.89	95.37	94.21	61.15	49.7	65.64	55.95	73.67	90.45	93.92	74.28	94.2	86.52
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.35	0.43	0.21	0.11	0.27
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09	0.34	0.43	0.16	0.11	0.27
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.07	0.31	0.4	0.16	0.1	0.23
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.23	0.46	0.59	31.69	0.26	0.41
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.23	0.46	0.59	24.06	0.26	0.41
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.17	0.42	0.55	23.41	0.24	0.36
CFO/Total Liabilities	-283.35	-151.7	-641.97	-403.17	-324.12	27.97	-29.94	-90	-84.74	-105.84	-184.47	-266.24	-17.86	-84.7	-29.39
CFO/CapEx	-782.5	-1,150.5	-566	-290.57	-4,946	517.22	-833	-2,931.4	-862.67	-151.71	-56.48	-56.29	-40.53	-467.33	-4.73
Altman's Z-Score	14.76	4.66	61.55	59.38	23.49	1.94	1.21	0.9	-1.35	1.47	35.27	26.13	0.33	5.04	1.8

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.74	0.4	-0.1	0.07	- -	- -	- -	- -	- -	3.23
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	490.89	913.48	-3,620.29	5,012.67	- -	- -	- -	- -	- -	113.16
Cash Conversion Cycle	- -	- -	- -	- -	- -	-490.89	-913.48	3,620.29	-5,012.67	- -	- -	- -	- -	- -	-113.16
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	20	26	58	102	65	95	118	86	58	83	695	476	93	97	112
- Cash & Cash Equivalents	2	4	2	2	3	4	4	5	3	19	77	40	9	54	46
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	-1	-1	-1	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	52	- -	1
Enterprise Value	18	21	49	81	48	64	98	56	25	43	602	320	-18	-46	-13
Total Capital	4	4	8	21	25	26	19	31	19	33	117	152	215	146	201
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.23	0.46	0.59	24.06	0.26	0.41
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.84	-0.01	-0.06
EV/Sales	- -	- -	- -	- -	- -	99.9	39.95	22.67	9.41	15.79	222.61	118.56	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	13.76	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	13.73	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	19	23	53	94	61	91	115	74	58	72	560	469	94	99	121
Diluted Enterprise Value	17	18	50	92	58	87	111	69	55	52	484	429	135	44	76
EV per Share	3.16	3.08	6.22	8.03	4.13	4.86	7.18	3.2	1.46	1.81	17.05	8.1	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	1	2	2	3	3	3	3	1	- -	2
TTM EBITDA	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15
TTM Operating Income	-2	-3	-4	-6	-7	-10	-11	-14	-15	-12	-24	-41	-16	-13	-15
TTM Cash Flow to Firm	-2	-2	-3	-4	-5	5	-6	-15	-13	-12	-21	-28	-8	-7	-9
TTM Free Cash Flow to Firm	-2	-2	-3	-4	-5	5	-6	-15	-13	-12	-21	-27	-8	-7	-7

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-11.06	-9.83	-15.5	-23.12	-12.3	19.52	-19.77	-5.03	-4.48	-5.8	-26.93	-17.11	-9.33	-11.78	-16.76
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	18	21	49	81	48	64	98	56	25	43	602	320	-18	-46	-13
Low Price	2.4	2.76	3.12	6.12	3.71	5.4	5.7	4.6	2.78	2.32	2.4	3.59	1.67	2	1.82
EV/Sales	- -	- -	- -	- -	- -	99.9	39.95	22.67	9.41	15.79	222.61	118.56	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.86	- -	1.84
Price/Earnings Average	-13.36	-6.68	-11.09	-17.4	-9.54	-8.65	-8.97	-9.11	-4.52	-6.69	-10.94	-8.39	21.27	-5.34	1.5
Price/Earnings High	-17.49	-9.29	-18.19	-51.49	-15.19	-12.37	-11.65	-13.26	-6.47	-10.79	-30.17	-15.75	100.19	-7.87	2.09
Price/Earnings Low	-8.33	-4.86	-5.31	-9.93	-5.55	-6.22	-7.24	-5.38	-3.38	-4.14	-3.07	-3.83	12.19	-4.29	1.18
Price/Book Value	5.46	6.78	7.12	4.93	2.62	3.63	6.15	2.76	2.98	2.51	6	3.14	0.57	0.66	0.56
Price/Book Value Average	6.04	6.7	6.36	5.21	2.97	3.78	5.02	4.35	3.33	2.7	2.6	2.05	0.72	0.68	0.46
Price/Book Value High	7.91	9.33	10.43	15.42	4.73	5.41	6.52	6.33	4.77	4.36	7.19	3.85	3.38	1	0.64
Price/Book Value Low	3.77	4.87	3.05	2.97	1.73	2.72	4.05	2.57	2.49	1.67	0.73	0.94	0.41	0.55	0.36
Price/Tangible Book Value	5.46	6.78	7.12	4.93	2.62	3.63	6.15	2.76	2.98	2.51	6	3.14	0.57	0.66	0.56
Price/Tangible Book Value Average	6.04	6.7	6.36	5.21	2.97	3.78	5.02	4.35	3.33	2.7	2.6	2.05	0.72	0.68	0.46
Price/Tangible Book Value High	7.91	9.33	10.43	15.42	4.73	5.41	6.52	6.33	4.77	4.36	7.19	3.85	3.38	1	0.64
Price/Tangible Book Value Low	3.77	4.87	3.05	2.97	1.73	2.72	4.05	2.57	2.49	1.67	0.73	0.94	0.41	0.55	0.36
Price/Sales	- -	- -	- -	- -	- -	142	46.88	30.08	21.44	26.44	207.28	173.56	69.5	- -	59
Price/Sales Average	- -	- -	- -	- -	- -	147.98	38.27	47.34	24	28.44	89.96	113.48	87.69	- -	48.17
Price/Sales High	- -	- -	- -	- -	- -	211.52	49.69	68.91	34.35	45.84	248.25	213.09	413.08	- -	67.07
Price/Sales Low	- -	- -	- -	- -	- -	106.35	30.89	27.95	17.95	17.58	25.28	51.79	50.24	- -	37.68
Price/Cash Flow	-11.05	-9.82	-15.48	-23.04	-12.29	19.55	-19.74	-5.03	-4.48	-5.76	-26.45	-16.8	-9.05	-11.75	-12.9
Price/Cash Flow Average	-12.23	-9.7	-13.82	-24.36	-13.94	20.38	-16.12	-7.91	-5.01	-6.19	-11.48	-10.99	-11.41	-12.11	-10.53
Price/Cash Flow High	-16	-13.5	-22.67	-72.1	-22.21	29.13	-20.93	-11.51	-7.18	-9.99	-31.68	-20.63	-53.77	-17.82	-14.67
Price/Cash Flow Low	-7.62	-7.06	-6.62	-13.91	-8.12	14.64	-13.01	-4.67	-3.75	-3.83	-3.23	-5.01	-6.54	-9.71	-8.24
Price/Free Cash Flow Average	-12.25	-9.71	-13.85	-24.45	-13.95	20.34	-16.14	-7.91	-5.02	-6.24	-11.69	-11.19	-11.78	-12.14	-13.69
Price/Free Cash Flow High	-16.02	-13.51	-22.71	-72.35	-22.21	29.07	-20.96	-11.52	-7.18	-10.05	-32.25	-21	-55.47	-17.86	-19.06
Price/Free Cash Flow Low	-7.63	-7.06	-6.64	-13.96	-8.12	14.62	-13.03	-4.67	-3.75	-3.85	-3.28	-5.11	-6.75	-9.73	-10.7
EV/Sales Average	- -	- -	- -	- -	- -	148.44	37.68	53.21	22.67	25.7	83.43	100.24	118.81	- -	23.13
EV/Sales High	- -	- -	- -	- -	- -	214.79	49.42	78.39	32.98	45.76	279.66	201.31	444.4	- -	41.06
EV/Sales Low	- -	- -	- -	- -	- -	104.97	30.11	30.59	16.65	13.18	3.23	37.66	81.35	- -	13.18
EV/EBITDA Average	-8.72	-7.28	-11.49	-18.06	-9.55	-9.51	-8.6	-9.64	-4.19	-5.93	-9.34	-6.68	-10.22	-3.54	-3.09
EV/EBITDA High	-11.6	-10.74	-19.19	-54.03	-15.47	-13.76	-11.27	-14.2	-6.1	-10.55	-31.31	-13.42	-38.24	-7.27	-5.49
EV/EBITDA Low	-5.2	-4.88	-5.23	-10.18	-5.38	-6.72	-6.87	-5.54	-3.08	-3.04	-0.36	-2.51	-7	-1.98	-1.76
EV/EBIT Average	-8.62	-7.24	-11.48	-18.04	-9.55	-9.51	-8.59	-9.63	-4.19	-5.92	-9.31	-6.67	-10.1	-3.49	-3.07
EV/EBIT High	-11.47	-10.68	-19.17	-53.98	-15.46	-13.75	-11.27	-14.19	-6.09	-10.55	-31.21	-13.4	-37.76	-7.16	-5.44
EV/EBIT Low	-5.14	-4.85	-5.23	-10.17	-5.38	-6.72	-6.86	-5.54	-3.08	-3.04	-0.36	-2.51	-6.91	-1.95	-1.75
Last Price	3.48	3.84	7.29	10.14	5.62	7.21	8.65	4.95	3.32	3.49	19.68	12.03	2.31	2.42	2.85
High Price	5.04	5.28	10.68	31.73	10.15	10.74	9.17	11.34	5.32	6.05	23.57	14.77	13.73	3.67	3.24
Enterprise Value Average	21	21	49	107	70	95	93	130	61	70	226	271	159	45	46
Enterprise Value High	28	31	83	319	114	138	121	192	89	124	756	544	595	92	82
Enterprise Value Low	13	14	22	60	40	67	74	75	45	36	9	102	109	25	26

Shares Outstanding	6	7	8	10	12	13	14	17	17	24	35	40	40	40	39
Diluted Weighted Avg Shares	5	6	7	9	11	13	13	15	17	21	28	39	41	41	42
Basic Weighted Avg Shares	5	6	7	9	11	13	13	15	17	21	28	39	40	41	41
Revenue per Share	- -	- -	- -	- -	- -	0.05	0.18	0.16	0.15	0.13	0.09	0.07	0.03	- -	0.05
EBITDA per Share	-0.44	-0.49	-0.6	-0.64	-0.68	-0.79	-0.81	-0.91	-0.84	-0.57	-0.85	-1.04	-0.39	-0.31	-0.36
Operating Income per Share	-0.45	-0.49	-0.6	-0.64	-0.68	-0.79	-0.81	-0.91	-0.84	-0.57	-0.85	-1.04	-0.39	-0.31	-0.36
Basic EPS, GAAP	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.78	-0.94	0.14	-0.47	1.55
Basic EPS from Cont Ops	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.81	-0.97	0.13	-0.47	1.55
Diluted EPS, GAAP	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.78	-0.94	0.14	-0.47	1.51
Diluted EPS from Cont Ops	-0.29	-0.57	-0.59	-0.62	-0.67	-0.87	-0.79	-0.86	-0.82	-0.56	-0.81	-0.97	0.13	-0.47	1.51
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.31	-0.39	-0.47	-0.44	-0.46	0.37	-0.44	-0.98	-0.74	-0.61	-0.74	-0.72	-0.26	-0.21	-0.22
Free Cash Flow per Basic Share	-0.32	-0.39	-0.47	-0.44	-0.46	0.37	-0.44	-0.99	-0.74	-0.61	-0.76	-0.73	-0.26	-0.21	-0.27
Cash & Equivalents per Share	0.32	0.76	1.07	2.11	1.49	2.35	1.47	1.75	1.86	1.69	2.67	3.94	4.02	3.56	3.21
Book Value per Share	0.64	0.57	1.02	2.06	2.15	1.99	1.41	1.79	1.12	1.39	3.28	3.84	4.06	3.66	5.09
Tangible Book Value per Share	0.64	0.57	1.02	2.06	2.15	1.99	1.41	1.79	1.12	1.39	3.28	3.84	4.06	3.66	5.09

Oramed Pharmaceuticals Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)